COVID-19 has challenged the pharma industry like never before. However, CROs and technology providers have partnered to develop innovative solutions that have transformed the drug development industry.

In this report, Medidata posed pressing questions to IDC analysts regarding key industry trends and challenges, including:

• How can CROs maintain a leadership position in this pandemic?
• How has COVID-19 affected the appetite for new technology among clinical trial sponsors? What has been the impact on CROs?
• What are the top challenges CROs are facing, and how are they leveraging technology to stay competitive during this pandemic?
• What are some key aspects of technology solutions and vendors that CROs consider as differentiating factors that help adapt to these changing circumstances?

About IDC Health Insights

IDC Health Insights works with healthcare and life science organizations throughout the world to help them provide value-based healthcare and knowledge-based medicine. Health Insights’ global team of analysts with decades of industry experience advises life science organizations on how to employ a more knowledge-centric approach to new drug development, disease diagnosis, management, and treatment.